BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Beyoğlu D, Idle JR. Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy. Metabolites 2020;10:E50. [PMID: 32012846 DOI: 10.3390/metabo10020050] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 Azbazdar Y, Demirci Y, Heger G, Karabicici M, Ozhan G. Comparative membrane lipidomics of hepatocellular carcinoma cells reveals diacylglycerol and ceramide as key regulators of Wnt/β-catenin signaling and tumor growth.. [DOI: 10.1101/2022.08.28.505578] [Reference Citation Analysis]
2 Beyoğlu D, Idle JR. The gut microbiota - a vehicle for the prevention and treatment of hepatocellular carcinoma. Biochem Pharmacol 2022;:115225. [PMID: 35998677 DOI: 10.1016/j.bcp.2022.115225] [Reference Citation Analysis]
3 Beyoğlu D, Park EJ, Quiñones-Lombraña A, Dave A, Parande F, Pezzuto JM, Idle JR. Addition of grapes to both a standard and a high-fat Western pattern diet modifies hepatic and urinary metabolite profiles in the mouse. Food Funct 2022. [PMID: 35876245 DOI: 10.1039/d2fo00961g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zeng Y, He H, An Z. Advance of Serum Biomarkers and Combined Diagnostic Panels in Nonalcoholic Fatty Liver Disease. Dis Markers 2022;2022:1254014. [PMID: 35811662 DOI: 10.1155/2022/1254014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Zhao F, Chen J, Guo R, Zhu J, Gu W, Li S, Li J. Absolute quantitative lipidomics reveals lipids profiling in liver of mice with early-stage alcoholic liver disease. Nutr Metab (Lond) 2022;19. [DOI: 10.1186/s12986-022-00679-z] [Reference Citation Analysis]
6 Beyoğlu D, Simillion C, Storni F, De Gottardi A, Idle JR. A Metabolomic Analysis of Cirrhotic Ascites. Molecules 2022;27:3935. [PMID: 35745058 DOI: 10.3390/molecules27123935] [Reference Citation Analysis]
7 Dawuti W, Zheng X, Liu H, Zhao H, Dou J, Sun L, Chu J, Lin R, Lü G. Urine surface-enhanced Raman spectroscopy combined with SVM algorithm for rapid diagnosis of liver cirrhosis and hepatocellular carcinoma. Photodiagnosis Photodyn Ther 2022;:102811. [PMID: 35304310 DOI: 10.1016/j.pdpdt.2022.102811] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
8 Marie B, Gallet A. Fish metabolome from sub-urban lakes of the Paris area (France) and potential influence of noxious metabolites produced by cyanobacteria. Chemosphere 2022;:134035. [PMID: 35183584 DOI: 10.1016/j.chemosphere.2022.134035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kubota N, Fujiwara N, Hoshida Y. Liver cancer risk-predictive molecular biomarkers specific to clinico-epidemiological contexts. Advances in Cancer Research 2022. [DOI: 10.1016/bs.acr.2022.01.005] [Reference Citation Analysis]
10 Depommier C, Everard A, Druart C, Maiter D, Thissen JP, Loumaye A, Hermans MP, Delzenne NM, de Vos WM, Cani PD. Serum metabolite profiling yields insights into health promoting effect of A. muciniphila in human volunteers with a metabolic syndrome. Gut Microbes 2021;13:1994270. [PMID: 34812127 DOI: 10.1080/19490976.2021.1994270] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
11 Shanmuganathan M, Sarfaraz MO, Kroezen Z, Philbrick H, Poon R, Don-Wauchope A, Puglia M, Wishart D, Britz-McKibbin P. A Cross-Platform Metabolomics Comparison Identifies Serum Metabolite Signatures of Liver Fibrosis Progression in Chronic Hepatitis C Patients. Front Mol Biosci 2021;8:676349. [PMID: 34414211 DOI: 10.3389/fmolb.2021.676349] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Beyoğlu D, Idle JR. Metabolic Rewiring and the Characterization of Oncometabolites. Cancers (Basel) 2021;13:2900. [PMID: 34200553 DOI: 10.3390/cancers13122900] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
13 Ji W, Peng Z, Sun B, Chen L, Zhang Q, Guo M, Su C. LpCat1 Promotes Malignant Transformation of Hepatocellular Carcinoma Cells by Directly Suppressing STAT1. Front Oncol 2021;11:678714. [PMID: 34178664 DOI: 10.3389/fonc.2021.678714] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Khalil A, Elfert A, Ghanem S, Helal M, Abdelsattar S, Elgedawy G, Obada M, Abdel-samiee M, El-said H. The role of metabolomics in hepatocellular carcinoma. Egypt Liver Journal 2021;11. [DOI: 10.1186/s43066-021-00085-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Mocan T, Kang DW, Molloy BJ, Jeon H, Spârchez ZA, Beyoğlu D, Idle JR. Plasma fetal bile acids 7α-hydroxy-3-oxochol-4-en-24-oic acid and 3-oxachola-4,6-dien-24-oic acid indicate severity of liver cirrhosis. Sci Rep 2021;11:8298. [PMID: 33859329 DOI: 10.1038/s41598-021-87921-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Demyanova EV, Shcherbakova ES, Sall TS, Bakulin IG, Vakhitov TY, Sitkin SI. Non-targeted Serum Metabolomics Identifies Candidate Biomarkers Panels Associated with Nonalcoholic Fatty Liver Disease: A Pilot Study in Russian Male Patients. TOBIOMJ 2021;11:17-27. [DOI: 10.2174/1875318302111010017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Pieters A, Gijbels E, Cogliati B, Annaert P, Devisscher L, Vinken M. Biomarkers of cholestasis. Biomark Med 2021;15:437-54. [PMID: 33709780 DOI: 10.2217/bmm-2020-0691] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Wu X, Lan T, Li M, Liu J, Wu X, Shen S, Chen W, Peng B. Six Metabolism Related mRNAs Predict the Prognosis of Patients With Hepatocellular Carcinoma. Front Mol Biosci 2021;8:621232. [PMID: 33869278 DOI: 10.3389/fmolb.2021.621232] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
19 Chen L, Jiang E, Guan Y, Xu P, Shen Q, Liu Z, Zhu W, Chen L, Liu H, Dong H. Safety of high-dose Puerariae Lobatae Radix in adolescent rats based on metabolomics. Food Sci Nutr 2021;9:794-810. [PMID: 33598164 DOI: 10.1002/fsn3.2044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Raees A, Kamran M, Özkan H, Jafri W. Updates on the Diagnosis and Management of Hepatocellular Carcinoma. Euroasian J Hepatogastroenterol 2021;11:32-40. [PMID: 34316462 DOI: 10.5005/jp-journals-10018-1335] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
21 Marie B, Gallet A. Fish metabolome from sub-urban lakes of the Paris area (France) and potential influence of noxious metabolites produced by cyanobacteria.. [DOI: 10.1101/2020.12.14.422619] [Reference Citation Analysis]
22 Rampler E, Abiead YE, Schoeny H, Rusz M, Hildebrand F, Fitz V, Koellensperger G. Recurrent Topics in Mass Spectrometry-Based Metabolomics and Lipidomics-Standardization, Coverage, and Throughput. Anal Chem 2021;93:519-45. [PMID: 33249827 DOI: 10.1021/acs.analchem.0c04698] [Cited by in Crossref: 49] [Cited by in F6Publishing: 56] [Article Influence: 24.5] [Reference Citation Analysis]
23 Rohwerder T. New structural insights into bacterial sulfoacetaldehyde and taurine metabolism. Biochem J 2020;477:1367-71. [PMID: 32322897 DOI: 10.1042/BCJ20200079] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Du Y, Chen L, Li XS, Li XL, Xu XD, Tai SB, Yang GL, Tang Q, Liu H, Liu SH, Zhang SY, Cheng Y. Metabolomic Identification of Exosome-Derived Biomarkers for Schizophrenia: A Large Multicenter Study. Schizophr Bull 2021;47:615-23. [PMID: 33159208 DOI: 10.1093/schbul/sbaa166] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
25 Beyoğlu D, Idle JR. Metabolomic insights into the mode of action of natural products in the treatment of liver disease. Biochemical Pharmacology 2020;180:114171. [DOI: 10.1016/j.bcp.2020.114171] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
26 Idle JR, Seipel K, Bacher U, Pabst T, Beyoğlu D. (2R,3S)-Dihydroxybutanoic Acid Synthesis as a Novel Metabolic Function of Mutant Isocitrate Dehydrogenase 1 and 2 in Acute Myeloid Leukemia. Cancers (Basel) 2020;12:E2842. [PMID: 33019704 DOI: 10.3390/cancers12102842] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
27 He Z, Luo Q, Liu Z, Gong L. Extensive evaluation of sample preparation workflow for gas chromatography-mass spectrometry-based plasma metabolomics and its application in rheumatoid arthritis. Analytica Chimica Acta 2020;1131:136-45. [DOI: 10.1016/j.aca.2020.06.029] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]